MCGIRR DAVID W J
SEC CIK 1219023 · EDGAR
BoughtSold
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
| 14 | MCGIRR DAVID W J | Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-25 18:08 | 2026-06-23 | RYTM | RHYTHM PHARMACEUTICALS, INC. | MCGIRR DAVID W J | Dir | M - OptEx | — | +4,712 | 11.7K | +67% | — |
| 2026-02-11 | 2026-02-09 | INSM | INSMED Inc | MCGIRR DAVID W J | Dir | G - Gift | $0.00 | -53.4K | 44.3K | -55% | $0 | |
| I | 2026-02-11 | 2026-02-09 | INSM | INSMED Inc | MCGIRR DAVID W J | Dir | G - Gift | $0.00 | +53.4K | 53.4K | New | $0 |
| D | 2025-06-23 | 2025-06-18 | RYTM | RHYTHM PHARMACEUTICALS, INC. | MCGIRR DAVID W J | Dir | M - OptEx | — | +4,000 | 7,000 | +133% | — |
| 2025-06-10 | 2025-06-09 | XFOR | X4 Pharmaceuticals, Inc | MCGIRR DAVID W J | Dir | A - Grant | $0.00 | +1,500 | 4,722 | +47% | $0 | |
| DM | 2025-06-05 | 2025-06-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | MCGIRR DAVID W J | Dir | S - Sale+OE | $65.22 | -65.4K | 12.9K | -84% | -$4.27M |
| D | 2025-06-05 | 2025-06-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | MCGIRR DAVID W J | Dir | M - OptEx | $4.59 | +65.4K | 68.4K | +2,181% | +$300.3K |
| M | 2025-06-04 | 2025-06-03+ | INSM | INSMED Inc | MCGIRR DAVID W J | Dir | S - Sale | $72.25 | -6,250 | 100.7K | -6% | -$451.5K |
| 2025-05-19 | 2025-05-15 | INSM | INSMED Inc | MCGIRR DAVID W J | Dir | A - Grant | — | +5,058 | 104.0K | +5% | — | |
| D | 2024-06-25 | 2024-06-21 | RYTM | RHYTHM PHARMACEUTICALS, INC. | MCGIRR DAVID W J | Dir | M - OptEx | — | +3,000 | 3,000 | New | — |
| 2024-06-11 | 2024-06-10 | XFOR | X4 Pharmaceuticals, Inc | MCGIRR DAVID W J | Dir | A - Grant | $0.00 | +45.0K | 96.7K | +87% | $0 | |
| 2024-05-15 | 2024-05-13 | INSM | INSMED Inc | MCGIRR DAVID W J | Dir | A - Grant | — | +13.2K | 98.9K | +15% | — | |
| 2023-06-14 | 2023-06-13 | XFOR | X4 Pharmaceuticals, Inc | MCGIRR DAVID W J | Dir | A - Grant | $0.00 | +45.0K | 51.7K | +675% | $0 | |
| 2023-05-15 | 2023-05-11 | INSM | INSMED Inc | MCGIRR DAVID W J | Dir | A - Grant | — | +13.2K | 85.8K | +18% | — | |
| 2022-06-27 | 2022-06-06 | XFOR | X4 Pharmaceuticals, Inc | MCGIRR DAVID W J | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 | |
| 2022-05-13 | 2022-05-11 | INSM | INSMED Inc | MCGIRR DAVID W J | Dir | A - Grant | — | +14.6K | 72.6K | +25% | — |
Purchase Sale Sale after option exercise All abbreviations